Financials in USD. Standardized financial statements.
A compact view of how China Medicine Corporation turns revenue into operating income and net income.
| Metric | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 |
|---|---|---|---|---|---|---|
| Revenue? | $64.75M | $53.65M | $42.11M | $23.99M | $0 | $10.40M |
| Revenue Growth? | +20.7% | +27.4% | +75.5% | 0.0% | -100.0% | 0.0% |
| Cost of Revenue? | $45.77M | $38.07M | $29.71M | $15.02M | $0 | $7.16M |
| Gross Profit? | $18.98M | $15.57M | $12.40M | $8.97M | $0 | $3.24M |
| Gross Margin? | +29.3% | +29.0% | +29.4% | +37.4% | 0.0% | +31.2% |
| Operating Expenses? | $6.72M | $4.65M | $3.98M | $2.79M | $32,500 | $823,496 |
| Operating Income? | $12.27M | $10.93M | $8.41M | $6.18M | -$32,500 | $2.42M |
| EBITDA? | $13.28M | $11.35M | $9.20M | $6.35M | -$32,500 | $2.54M |
| Income Before Tax | $4.95M | $11.01M | $8.43M | $5.98M | $0 | $2.43M |
| Income Tax Expense | $3.55M | $2.01M | $1.65M | $1.23M | $32,500 | -$509,031 |
| Net Income? | $1.72M | $9.13M | $6.88M | $4.79M | -$32,500 | $2.94M |
| EPS? | $0.11 | $0.60 | $0.56 | $0.65 | $-0.01 | $0.41 |
| Diluted EPS? | $0.11 | $0.60 | $0.50 | $0.63 | $-0.01 | $0.39 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality